Sunday, 26 May 2019

Specials News

  • TCM leader Yunnan Baiyao rides on R&D strength

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jun, 2013

    Yunnan Baiyao Group is expanding its forte in the domain of traditional Chinese medicines and is concentrating on strengthening its R&D base. Recognized as a leading traditional Chine...Read more

  • VeriStem wins BioSpectrum award for stem cell technology

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Development of stem cell therapies requires innovative technologies and processes to overcome safety concerns and VeriStem Technologies of Singapore aims to fulfil this industry need. The c...Read more

  • AseaCyte predicts cell behaviour for future therapies

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 10 Jan, 2013

    Malaysia-based AseaCyte is emerging as an instrumental firm in the domain of human disease analysis, through its cell culture technology and cell-based analysis services. The start-up compa...Read more

  • Guangzhou records a whopping growth of over 50%

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Clocking $1.3 billion revenue in 2012, Guangzhou Pharmaceutical recorded a growth of over 50 percent. A well-recognized name in China, Guangzhou Pharmaceutical Holdings is principally eng...Read more

  • What bioscience trends do the industry leaders predict for 2013?

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 03 Jan, 2013

    The bioscience industry is about to step into 2013 and the year is predicted to unfold with new opportunities and trends that were so far just talk in the laboratories. First and foremost, ...Read more

  • What are the key mergers & acquisitions of Q1 2013?

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Most pharmaceutical companies are sitting on the patent cliff and their drug pipelines are facing severe exhaustion. The big players of the industry are thus looking for mergers & acqui...Read more

  • What were the top 20 M&A deals in pharma and biotech sector in 2012?

    Specials |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    A majority of life science firms are standing on the edge of the patent cliff and their drug pipelines are experiencing acute scarcity. This is making them seek out partners for mergers &am...Read more

  • Tackling TB in Asia

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 23 Mar, 2012

    Nearly three million new TB cases occur in South East Asia per year. Annually, about 700,000 women die of TB in Asia, and over three million contract the disease, accounting for about 17 mi...Read more

  • We have largest portfolio of new TB drugs'

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2012

    The Global Alliance for TB Drug Development (TB Alliance) is a non-profit organization dedicated to the discovery and development of new, faster-acting and affordable tuberculosis medicines...Read more

  • How is India tackling the scourge of TB?

    Specials |  News | By Nandita Singh | 0 Comment | 23 Mar, 2012

    The fact that one-fifth of the world's TB patients are in India (according to WHO) acts as a good catalyst for companies to set up their production units. Also, the vast pool of diseased su...Read more

  • Sandoz focuses on developing modern drugs for TB'

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2012

    Sandoz is the generic drug subsidiary of Novartis, a multinational pharmaceutical company. The company develops, manufactures and markets generic drugs as well as pharmaceutical and biotech...Read more

  • Our new compund TMC207 will be the solution for MDR-TB'

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2012

    Tibotec is an international pharmaceutical company, accelerating discovery and development of breakthrough drugs in HIV/AIDS and other therapeutic diseases. Dr Koen Andries, distinguished r...Read more

  • AseaCyte gets BioSpectrum award for drug discovery efforts

    Specials |  Influencers | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    A meeting between Dr Teo Soo Hwang, current CEO of AseaCyte; Dr Lee Hong Boon from Cancer Research Initiatives Foundation (CARIF), a non-profit cancer research institute in Malaysia; and Dr...Read more

  • Multi-drug resistant TB is on the increase'

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 22 Mar, 2012

    The Global Fund to Fight AIDS, Tuberculosis and Malaria, is a public-private partnership dedicated to attracting and disbursing additional resources to prevent and treat AIDS, TB and malari...Read more

  • Indian generic drug makers can play a role in curing TB'

    Specials |  News | By Nandita Singh | 0 Comment | 22 Mar, 2012

    The Stop TB Partnership was established in 2000 to realize the goal of eliminating Tuberculosis (TB) as a public health problem and, ultimately, to obtain a world free of TB. It comprises a...Read more

  • TB research crucibles looking for new drug

    Specials |  News | By BioSpectrum Bureau  | 0 Comment | 23 Mar, 2012

    Low monetary return on TB drug R&D has prevented even the biggest of pharmaceutical and biotech companies from venturing in to the search for new TB drugs. However, several organization...Read more

  • Potential early warning signs of osteoporosis found in South Asian women

    Specials |  News | 0 Comment | 14 Mar, 2017

    Pre-menopausal South Asian women could be more at risk of developing osteoporosis in later life than white Caucasian women, a new study in the Journal Bone reports.  In the first stud...Read more

Podcast

 

Survey Box

Will stem cell therapy market witness highest growth in Asia by 2020?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls